Inflammation of the gastrointestinal tract is a complex biological response to harm caused by bacteria, damaged cells, or irritants. The symbiotic microbiome in the digestive tract is thought to protect the gut by eliminating unwanted stimuli and promoting recovery. The presence or lack of a microbiome can cause type 2 immunity to be worsened, as well as allergic/infectious and inflammatory consequences, including parasitic diseases. Inflammation of the gastrointestinal tract is frequently accompanied by changes in vascular anatomy and function. Microvascular congestion, Dilatation of the arteries supplying the tissue, and excessive fluid and protein leakage with interstitial oedema are examples of these disorders. IBD medications can often reduce inflammation and improve intestinal healing, leading in remission—long-term symptom relief. Many persons with IBD, however, have a chronic illness that requires lifelong therapy.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Title : The role of G-tube placement for neurologic injury patients
Brandon Lucke Wold, University of Florida, United States
Title : Peptidase inhibitor 3 [PI3) contribution to risk of celiac disease. Functional characterization of polymorphisms in the PI3 gene
Maria Isabel Torres Lopez, University of Jaen, Spain
Title : Menetrier's disease presenting as gastric outlet obstruction mimicking linitis plastica: A case report
Erika Johanna P Tanada, University of Santo Tomas Hospital, Philippines
Title : Endoscopic resection of a granular cell tumor: A case report
Omar Ahmed Alomair, King Faisal University, Saudi Arabia